Diet, Genomics and Immunology Lab Site Logo
ARS Home About Us Helptop nav spacerContact Us En Espanoltop nav spacer
Printable VersionPrintable Version E-mail this pageE-mail this page
Agricultural Research Service United States Department of Agriculture
Search
  Advanced Search
 
Programs and Projects
Subjects of Investigation
 

Research Project: EFFECTS OF PHENOLIC PHYTOCHEMICALS ON CANCER: ABSORPTION, MOLECULAR ACTIONS AND GENE RESPONSE

Location: Diet, Genomics and Immunology Lab

2007 Annual Report


1a.Objectives (from AD-416)
1) To synthesize N-coumaroyltyramine and its analogues and to identify their cellular effects and molecular mechanisms, particularly as related to cancer modulation,.
2)To assess anti-cancer and other health effects N-coumaroyltyramine and its analogues in an animal model.


1b.Approach (from AD-416)
1. Synthesis of phenylpropenic acid conjugates (N-coumaroyltyramine and its analogues). 2. Measurement of phenylpropenic acid conjugates in cell and biological samples. 3. Investigation of effects of phenylpropenic acid conjugates on cell cycle and growth of cancer cells. 4. Apoptosis study. 5. Hydrogen peroxide quenching study. 6. Investigation of effects of phenylpropenic acid conjugates on MAPK Kinases. 7. Investigation of effects of phenylpropenic acid conjugates on protein tyrosine kinase including EGFR. 8. Investigation of effects of phenylpropenic acid conjugates on xenograft tumor in nude mice.


3.Progress Report
The lead scientist established a Phytochemical Database: that provides information on phytochemicals, medicinal plants, herbs and spices, medicines, and supplements that have phyochemicals as a basic ingredient. The website provides information and links to additional data on studies that show the interaction between phytochemical composition in the diet and conditions such as obesity, diabetes, aging, hypertension, heart disease, and inflammation.


4.Accomplishments
Synthesized of Clovamide-type Polyphenols to Evaluate Anti-inflammatory Properties in Animal Models: More than 50 clovamide-type phenylpropenoic acid amides found in coffee, cocoa, tea, and other plant sources were synthesized, purified, and investigated to determine their effects on P-selectin expression and platelet-leukocyte interactions found in blood cells. N-caffeoyldopamine and N-caffeoyltyramine were the most potent phenolic conjugates in blood cells, inhibiting P-selectin expression and platelet-leukocyte interactions in vitro and in vivo models. N-caffeoyldopamine and N-caffeoyltyramine were found to contain both COX inhibitory and cAMP producing activities which are key inflammatory mediators. The dual activities of these compounds suggests that they may be important in preventing human cardiovascular and inflammatory diseases that are treated typically with drugs that are COX inhibitors that often cause adverse effects. In addition, the bioavailability of safflomide (a phenolic conjugate) was determined for the first time using mouse models. This research addresses Component 5 of the National Program 107 Action Plan: “Identifying the Health Promoting Properties of Plant and Animal Foods”.


5.Significant Activities that Support Special Target Populations
None


6.Technology Transfer
Number of new CRADAs and MTAs1
Number of invention disclosures submitted1
Number of web sites managed1

Review Publications
Park, J.B. 2007. Caffedymine from cocoa has COX inhibitory activity suppressing the expression of a platelet activation marker, P-selectin. Journal of Agricultural and Food Chemistry.(6):2171-5.

Park, J.B., Chen, P. 2007. Synthesis of safflomide and its HPLC measurement in mouse plasma after oral administration. Journal of Chromatography B: Biomedical Applications. 852(1-2):398-402.

   

 
Project Team
Park, Jae
 
Project Annual Reports
  FY 2009
  FY 2008
  FY 2007
  FY 2006
  FY 2005
 
Publications
   Publications
 
Related National Programs
  Human Nutrition (107)
 
 
Last Modified: 05/22/2013
ARS Home | USDA.gov | Site Map | Policies and Links 
FOIA | Accessibility Statement | Privacy Policy | Nondiscrimination Statement | Information Quality | USA.gov | White House